VIGABATRIN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 67877-674
  • Package NDC 67877-674-63
  • Application number ANDA213375
  • SPL ID e55f8225-aa06-4e46-81d2-757233b95585
  • SPL set ID ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8
  • UNII GR120KRT6K
  • RxCUI 250820

What the source publishes

Labeler
Ascend Laboratories, LLC
Active ingredients
VIGABATRIN
Form
POWDER, FOR SOLUTION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:67877-674_e55f8225-aa06-4e46-81d2-757233b95585
{
  "name": "VIGABATRIN",
  "splId": "e55f8225-aa06-4e46-81d2-757233b95585",
  "labels": [
    {
      "setId": "ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Ascend Laboratories, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "50 PACKET in 1 CARTON (67877-674-63)  / 10 mL in 1 PACKET",
      "package_ndc": "67877-674-63",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20201203"
    }
  ],
  "productId": "67877-674_e55f8225-aa06-4e46-81d2-757233b95585",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SOLUTION",
  "productNdc": "67877-674",
  "deaSchedule": null,
  "genericName": "VIGABATRIN",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "VIGABATRIN",
      "strength": "50 mg/mL"
    }
  ],
  "applicationNumber": "ANDA213375",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20201203",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175753"
    ],
    "upc": [
      "0367877674636"
    ],
    "unii": [
      "GR120KRT6K"
    ],
    "rxcui": [
      "250820"
    ],
    "spl_set_id": [
      "ee835fb6-2b2b-40c4-b6d7-0ad0e790cda8"
    ],
    "pharm_class_epc": [
      "Anti-epileptic Agent [EPC]"
    ],
    "manufacturer_name": [
      "Ascend Laboratories, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:67877-674_e55f8225-aa06-4e46-81d2-757233b95585"